Moderna, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0QF.F | 6547.TWO | 261780.KQ | 0A3M.IL | 0MGB.IL | VIR | |
|---|---|---|---|---|---|---|
| Market cap | 90.69B | 15.63B | 103.62B | 25.17B | 295.78B | 1.99B |
| P/E (TTM) | — | — | — | 5.1 | 52.2 | — |
| Forward P/E | — | 32.6 | — | 5.1 | — | -4.8 |
| Price/book | 15.1 | 4.4 | — | 1.1 | 8.4 | 2.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +892.01% | +42.31% | +44.97% | −16.75% | +93.74% | +129.88% |
| Today | +0.07% | −2.16% | −2.90% | +2.81% | +1.96% | +4.90% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 0QF.F news ›Moderna's Cancer Vaccine Is Incredibly Promising, but This Could Be a Major Obstacle to Its Success
Moderna and Merck have developed a cancer vaccine that has been highly effective in treating melanoma patients. In a late-stage trial, it reduced the risk of death and melanoma recurrence by 42% when paired with Keytruda. The problem is…
Could Investing in Moderna's Stock Double Your Money?
The healthcare stock has generated massive returns this year and may still have room to rise even higher in the future. Moderna (MRNA +3.45%) has generated terrific gains for investors this year, as the stock has skyrocketed more than 650%…
Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
Moderna surges on pre-earnings momentum, Pfizer dips after beating estimates and raising guidance, and Merck drops despite launching a new trial. When stock prices and headlines point in opposite directions across the sector, something…
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
BioSpace Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (NASDAQ: PSNL) announced today
Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial
WJAR Moderna-Merck personalized mRNA melanoma vaccine cuts relapse risk in late-stage trial
Moderna, Inc. $MRNA Stock Sold by Bank Julius Baer & Co. Ltd Zurich
MRNA stock opened at $220.83 on Tuesday. The stock has a 50-day moving average price of $184.00 and a two-hundred day moving average price of $87.42. The company has a current ratio of 2.29, a quick ratio of 2.18 and a debt-to-equity ratio…
If Moderna's CEO Is Right, the Stock's Rally Could Just Be Getting Started
Stéphane Bancel has high hopes for the company's cancer vaccine, beyond just treating melanoma. Moderna (MRNA +0.13%) has been the hottest stock in the S&P 500 this year, and it hasn't been close. Up around 650%, the next-best-performing…
Stock Split Watch: Is Moderna Next?
The biotech quickly took charge of the situation, cutting costs where needed and putting a focus on oncology and rare disease candidates. All of these efforts have started to brighten Moderna's earnings reports, and investors have sat up…
Bronstein, Gewirtz & Grossman, LLC Is Investigating Moderna, Inc. (MRNA) And Encourages Stockholders to Connect
The National Law Review Bronstein, Gewirtz & Grossman, LLC Is Investigating Moderna, Inc. (MRNA) And Encourages Stockholders to Connect On October 22, 2026, an early release of closely wa
Biotech Stocks Beat The S&P500 – Can Pfizer, Novo And Moderna Earnings Keep The Rally Going?
Biotech stocks head into a busy earnings week after beating the broader market, with Pfizer, Novo Nordisk and Moderna set to report earnings alongside a fresh round of cancer-treatment data. Healthcare and biotech rallied the previous…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- 247wallst.com22
- marketscreener.com22
- seekingalpha.com20
- theglobeandmail.com17
- fool.com15
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.